Results 241 to 250 of about 25,762 (279)

Effectiveness and safety of ravulizumab for Japanese patients with atypical hemolytic uremic syndrome switched from eculizumab: an analysis of a post-marketing surveillance. [PDF]

Clin Exp Nephrol
Ito S, Hataya H, Matsumoto M, Shimono A, Teranishi H, Okuda M, Miyakawa Y, Maruyama S.   +7 more
europepmc   +1 more source

[Ultra-early administration of eculizumab in a child with atypical hemolytic uremic syndrome: a case report]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Guo DD, Xiao YX, Wang WR, Deng XL, Huang YH.   +4 more
europepmc   +1 more source

Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab. [PDF]

Haematologica
Ardissino G, Angelillo P, Mancuso MC, Griffini S, Grovetti E, Porcaro L, Ria T, Marktel S, Peyvandi F, Luminari S, Ferreri AJM, Merli M, Cugno M.   +12 more
europepmc   +1 more source

A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture. [PDF]

Nephrology (Carlton)
Kano T, Io H, Sasaki Y, Muto M, Muto S, Ogiwara K, Ikeda A, Iwasaki H, Suzuki Y.   +8 more
europepmc   +1 more source

Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series. [PDF]

Drug Target Insights
Livia Maria S, Iacuzzo C, Sciri R, Zacchia M, Iannuzzi M, Marotta P, Vitale P, Taglioni C, Secondulfo F, Palazzetti D, Baccaro R.   +10 more
europepmc   +1 more source

Case Report: Life-threatening overlap of hemophagocytic syndrome and atypical hemolytic uremic syndrome in a patient with autoimmune polyglandular syndrome type 1 successfully treated with targeted immunotherapy. [PDF]

Front Immunol
Coppola E, Giardino G, Romano R, Capalbo D, Italiani P, Boraschi D, De Rosa A, Toriello E, Palatucci A, Rubino V, Ruggiero G, Salerno M, Pignata C, Cirillo E.   +13 more
europepmc   +1 more source

Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review. [PDF]

BMC Nephrol
Musalem P.
europepmc   +1 more source

High prevalence of the hotspot complement factor I p.Ile357Met pathogenic variant in Tunisian atypical hemolytic uremic syndrome patients: report of three new cases and review of the literature. [PDF]

Front Immunol
Tajouri A, Ayadi I, BenBrahim R, Mami I, Boussetta A, Jlajla H, Zerzeri Y, Arbi Sassi H, Ben Sassi J, Sahli H, Laadhar L, Gargah T, Zouaghi MK, Kallel Sellami M.   +13 more
europepmc   +1 more source

Exploring the Intersection of Atypical Hemolytic Uremic Syndrome and Substance Use: A Comprehensive Narrative Review. [PDF]

Cureus
Akbariansaravi A, Dekhne A, Dhamelia A, Mekhail M.   +3 more
europepmc   +1 more source

Hemolytic uremic syndrome with Mycoplasma pneumoniae infection and membrane cofactor protein mutation [PDF]

, 2016
Csuka, Dorottya, Drożdż, Dorota, Miklaszewska, Monika, Pállinger, Éva, Takács, Beáta, Zachwieja, Katarzyna   +5 more
core